NCT06361186View on ClinicalTrials.gov

Proximod Pharmacokinetics In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

September 14, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

June 22, 2021

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Proximod

Single and multiple-dose to establish the safety and PK profile

DRUG

Placebo

Placebo controlled

Trial Locations (1)

Unknown

The first hospital of Jilin University, Changchun

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Longevity Inc.

INDUSTRY

NCT06361186 - Proximod Pharmacokinetics In Healthy Subjects | Biotech Hunter | Biotech Hunter